Sep 14, 2022 / 08:00AM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good evening -- Good afternoon, everyone. Welcome to Bank of America's Global Healthcare Conference. I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst. Our next company today is Qiagen. From Qiagen, we have CFO, Roland Sackers; and we have Head of IR, John Gilardi. Gentlemen, thank you for being here.
Roland Sackers - Qiagen N.V. - CFO, MD & Member of Management Board
Thanks.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchI guess to start, what -- sort of like, any opening remarks? It's like -- everybody is obviously worried about demand, say, the businesses, just like any -- you want to sort of like summarize what you saw coming out the second quarter? There was a lot fears in China, there's a lot of fears of stuff like this. Do you want to do some open remarks, so we can start the inquisition?
Roland Sackers - Qiagen N.V. - CFO
Trustpilot
